Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.

Autor: Jog NR; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States., James JA; Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.; Departments of Medicine, Pathology, Microbiology & Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Feb 03; Vol. 11, pp. 623944. Date of Electronic Publication: 2021 Feb 03 (Print Publication: 2020).

Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.

Autor: Jog NR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Young KA; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, Colorado, USA., Munroe ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Harmon MT; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Guthridge JM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Kelly JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Gilkeson GS; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Weisman MH; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Karp DR; Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Gaffney PM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA., Harley JB; Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.; US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States., Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA., Norris JM; Department of Epidemiology, University of Colorado Anschutz Medical Campus, Colorado School of Public Health, Aurora, Colorado, USA., James JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA judith-james@omrf.org.; Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Sep; Vol. 78 (9), pp. 1235-1241. Date of Electronic Publication: 2019 Jun 19.

Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.

Autor: Corradetti C; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140., Jog NR; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104., Cesaroni M; Janssen Research and Development, LLC, Spring House, PA 19477; and., Madaio M; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912., Caricchio R; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140; roc@temple.edu.

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2018 Jan 15; Vol. 200 (2), pp. 512-522. Date of Electronic Publication: 2017 Dec 13.

Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

Autor: Jog NR; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.; Current affiliation: Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA., Blanco I; Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA., Lee I; Nephrology Section, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA., Putterman C; Division of Rheumatology, Albert Einstein College of Medicine, Bronx, NY, USA., Caricchio R; Rheumatology Section, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA roc@temple.edu.; Department of Microbiology and Immunology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.

Publikováno v: Lupus [Lupus] 2016 Dec; Vol. 25 (14), pp. 1551-1557. Date of Electronic Publication: 2016 Apr 12.

SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore.

Autor: Shanmughapriya S; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Rajan S; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Hoffman NE; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Higgins AM; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Tomar D; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Nemani N; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Hines KJ; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Smith DJ; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Eguchi A; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Vallem S; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Shaikh F; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Cheung M; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Leonard NJ; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Stolakis RS; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Wolfers MP; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Ibetti J; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA., Chuprun JK; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA., Jog NR; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA., Houser SR; Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA., Koch WJ; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA., Elrod JW; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA 19140, USA., Madesh M; Department of Biochemistry, Temple University School of Medicine, Philadelphia, PA 19140, USA; Center for Translational Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA; Cardiovascular Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA. Electronic address: madeshm@temple.edu.

Publikováno v: Molecular cell [Mol Cell] 2015 Oct 01; Vol. 60 (1), pp. 47-62. Date of Electronic Publication: 2015 Sep 17.